Treatment

RO7795081 clinical trials

Active studies that list RO7795081 as an intervention or treatment.

3active studies

1recruiting now

6countries represented

50largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 1

Overweight, ObesityCondition

RO7795081, PlaceboTreatment

Netherlands1 locations

Hoffmann-La RocheSponsor

Updated 2026-09-03 · NCT06982131See eligibility →

Active, not recruitingPhase 1

Healthy Volunteers, Overweight or ObesityCondition

RO7795081, PlaceboTreatment

China2 locations

Hoffmann-La RocheSponsor

Updated 2026-08-10 · NCT07499050See eligibility →

Active, not recruitingPhase 2

Type 2 Diabetes MellitusCondition

RO7795081, SemaglutideTreatment

Hungary, Poland50 locations

Hoffmann-La RocheSponsor

Updated 2026-07-07 · NCT07112872See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.